Immune checkpoint inhibitor (ICI)-induced hepatitis diagnosed by liver biopsy followed by ICI-free chemotherapy leading to therapeutic effect: A case of lung cancer treatment

Immune checkpoint inhibitor (ICI)-induced hepatitis diagnosed by liver biopsy followed by ICI-free chemotherapy leading to therapeutic effect: A case of lung cancer treatment

Show other versions (1)

In recent years, the combination of platinum-based chemotherapy and immune checkpoint inhibitors (ICIs) has become the standard treatment for patients with lung cancer. Hepatitis is one of the common toxicities following ICI/chemotherapy. When drug-induced hepatitis occurs, the suspected drug must b...

Full description

Bibliographic Details
Main Authors: Takae Okuno, Kazuhisa Nakashima, Yuki Mitarai, Masatoshi Kataoka, Hiroshi Tobita, Mamiko Nagase, Takeshi Isobe, Yukari Tsubata
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Non-small cell lung cancer
Immune checkpoint inhibitor
Immune-related adverse events
Hepatitis
Liver biopsy
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007122001757

Internet

http://www.sciencedirect.com/science/article/pii/S2213007122001757

Similar Items